Cognitive-behavioral Therapy for Avoidant/restrictive Food Intake Disorder: Feasibility, Acceptability, and Proof-of-concept for Children and Adolescents
Overview
Authors
Affiliations
Objective: Little is known about the optimal treatment of avoidant/restrictive food intake disorder (ARFID). The purpose of this study was to evaluate feasibility, acceptability, and proof-of-concept for cognitive-behavioral therapy for ARFID (CBT-AR) in children and adolescents.
Method: Males and females (ages 10-17 years) were offered 20-30 sessions of CBT-AR delivered in a family-based or individual format.
Results: Of 25 eligible individuals, 20 initiated treatment, including 17 completers and 3 dropouts. Using intent-to-treat analyses, clinicians rated 17 patients (85%) as "much improved" or "very much improved." ARFID severity scores (on the Pica, ARFID, and Rumination Disorder Interview) significantly decreased per both patient and parent report. Patients incorporated a mean of 16.7 (SD = 12.1) new foods from pre- to post-treatment. The underweight subgroup showed a significant weight gain of 11.5 (SD = 6.0) pounds, moving from the 10th to the 20th percentile for body mass index. At post-treatment, 70% of patients no longer met criteria for ARFID.
Discussion: This is the first study of an outpatient manualized psychosocial treatment for ARFID in older adolescents. Findings provide evidence of feasibility, acceptability, and proof-of-concept for CBT-AR. Randomized controlled trials are needed.
Neural Response to Food Cues in Avoidant/Restrictive Food Intake Disorder.
Thomas J, Holsen L, Van De Water A, Becker K, Breithaupt L, Burton-Murray H JAMA Netw Open. 2025; 8(2):e2460101.
PMID: 39964683 PMC: 11836757. DOI: 10.1001/jamanetworkopen.2024.60101.
Liu M, Chang Y, Xie X, Liu Y, Tian S, Yang C Front Psychiatry. 2025; 15:1450800.
PMID: 39882163 PMC: 11775632. DOI: 10.3389/fpsyt.2024.1450800.
Dumont E, Tiemens D, Draaisma J, Kleimeier L, van Druten D, Mulkens S Eur J Pediatr. 2024; 184(1):100.
PMID: 39710790 DOI: 10.1007/s00431-024-05933-5.
Estrem H, Pederson J, Dodrill P, Romeo C, Thompson K, Thomas J Int J Eat Disord. 2024; 58(3):489-499.
PMID: 39679744 PMC: 11891627. DOI: 10.1002/eat.24349.
Nocerino R, Mercuri C, Bosco V, Giordano V, Simeone S, Guillari A Nutrients. 2024; 16(17).
PMID: 39275348 PMC: 11397472. DOI: 10.3390/nu16173034.